The Long COVID-19 Wearable Device Study

Description

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

Conditions

Long COVID, Postural Orthostatic Tachycardia Syndrome, Dysautonomia, Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Long Covid19

Study Overview

Study Details

Study overview

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

The Long COVID-19 Wearable Device Study

The Long COVID-19 Wearable Device Study

Condition
Long COVID
Intervention / Treatment

-

Contacts and Locations

La Jolla

Scripps Research, La Jolla, California, United States, 92037

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Is at least 18 years old.
  • * Has a self/and or physician diagnosis of:
  • * Long COVID (based on the WHO working definition),
  • * ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or
  • * POTS (Postural Orthostatic Tachycardia Syndrome).
  • * Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms.
  • * Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one.
  • * Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly.
  • * Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback.
  • * Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies.
  • * Agrees to complete at least 75% of the study surveys.
  • * As long as they meet inclusion there is no exclusion

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Scripps Translational Science Institute,

Study Record Dates

2025-12-01